EHR Data Refine Risk Prediction for Post-PCI Readmission

This article originally appeared here.
Share this content:
EHR Data Refine Risk Prediction for Post-PCI Readmission
EHR Data Refine Risk Prediction for Post-PCI Readmission

WEDNESDAY, Aug. 19, 2015 (HealthDay News) -- Patient characteristics extracted from their electronic health records can be used to refine risk prediction for hospital readmission after percutaneous coronary intervention, according to a study published online Aug. 18 in Circulation: Cardiovascular Quality and Outcomes.

Jason H. Wasfy, M.D., M.Phil., from Massachusetts General Hospital in Boston, and colleagues matched readmitted to non-readmitted patients in a 1:2 ratio by risk of readmission in an effort to improve ability to predict 30-day readmission after percutaneous coronary intervention. Unstructured and structured data were extracted from the electronic health record for 888 readmitted patients and 1,776 non-readmitted patients.

The researchers found that cases and controls differed significantly with respect to interpreter (7.9 and 5.3 percent, respectively; P = 0.009), emergency department visits (1.12 and 0.77, respectively; P < 0.001), homelessness (3.2 and 1.6 percent, respectively; P = 0.007), anticoagulation (33.9 and 22.1 percent, respectively; P < 0.001), atrial fibrillation/flutter (32.7 and 28.9 percent, respectively; P = 0.045), presyncope/syncope (27.8 and 21.3 percent, respectively; P < 0.001), and anxiety (69.4 and 62.4 percent, respectively; P < 0.001) in univariate analyses. There were independent associations for anticoagulation, emergency department visits, and anxiety with readmission.

"These results have the potential to improve risk assessment for early readmission after percutaneous coronary intervention, and emphasize the role of unmeasured confounders in risk assessment," the authors write.

Several authors disclosed financial ties to the pharmaceutical and medical technology industries.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »